No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Genomics BioSci & Tech. Co.,Ltd. specializes in providing a comprehensive array of services within the field of genomic sequencing. Its core offerings encompass standard and intricate DNA sequencing, including TAF-certified options, with clients also benefiting from complimentary sequencing primer and primer walking services. Beyond sequencing, the company is proficient in synthesizing peptides, genes, and oligonucleotides. Furthermore, its analytical capabilities extend to crucial laboratory services such as sample preparation, gene expression analysis, genotyping, DNA methylation analysis, and microbial identification. The firm also delivers advanced sequencing solutions, including genome-level, targeted, gene regulation, and metagenomic sequencing, alongside cutting-edge third-generation sequencing technologies. To support these services, it offers integrated sequencing platforms and streamlined workflows. Additionally, Genomics BioSci & Tech. Co.,Ltd. provides specialized diagnostic screenings, such as non-invasive prenatal testing (NIPT), spinal muscular atrophy (SMA) carrier screening, and fragile X syndrome premutation screening. Established in 2001, the company's headquarters are located in New Taipei City, Taiwan.
www.genomics.com.twNo one on the platform currently holds 4195.TWO.
No tracked institution reports a position in 4195.TWO as of their last filing.
No one on the platform has traded 4195.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4195.TWOGenomics BioSci & Tech. Co.,Ltd. | $29.45 | +0.00% | $2.4B | — |
| 1762.TWChunghwa Chemical Synthesis & Biotech Co., Ltd. | $33.80 | +0.45% | $2.6B | — |
| 4168.TWOGlycoNex Incorporation | $21.80 | +1.16% | $2.5B | — |
| 4171.TWOGeneReach Biotechnology Corp. | $16.50 | +1.23% | $945M | — |
| 4724.TWOMeribank Biotech Co., Ltd | $10.30 | +16.12% | $989M | — |
| 6564.TWOEnimmune corporation | $16.95 | +0.89% | $1.2B | — |
| 6676.TWOSunny Pharmtech Inc. | $11.15 | -0.45% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry